Brief: Bioarctic Leqembi® Approved For Iv Maintenance Treatment In China
29/09/2025 07:25
Sept 29 (Reuters) - BioArctic AB BIOAb.ST: LEQEMBI® APPROVED FOR IV MAINTENANCE TREATMENT IN CHINA Source text: ID:nWkr5LHr9V Further company coverage: [BIOAb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on BioArctic AB
See all newsBrief: BioArctic And Lilly Sign Research, Collaboration Agreement
Brief: Bioarctic AB Declares Dividend Of Sek 2 Per Share With 1 June 2026 Record Date
Brief: Bioarctic Partner Eisai Presents Leqembi Sales Simulation
Sweden's BioArctic Q1 revenue drops sharply despite higher Leqembi royalties
Brief: BioArctic Q1 Operating Profit SEK 210.8 Million